These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 852498)

  • 21. Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effects.
    Bertilsson L; Nordin C; Otani K; Resul B; Scheinin M; Siwers B; Sjöqvist F
    Clin Pharmacol Ther; 1986 Sep; 40(3):261-7. PubMed ID: 3742932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.
    Alexanderson B
    Eur J Clin Pharmacol; 1972 Mar; 4(2):82-91. PubMed ID: 4655685
    [No Abstract]   [Full Text] [Related]  

  • 23. Sampling time, dosage schedule, and nortriptyline plasma levels.
    Ziegler VE; Knesevich JW; Wylie LT; Biggs JT
    Arch Gen Psychiatry; 1977 May; 34(5):613-5. PubMed ID: 871235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interindividual differences in amitriptyline demethylation.
    Rollins DE; Alván G; Bertilsson L; Gillette JR; Mellström B; Sjöqvist F; Träskman L
    Clin Pharmacol Ther; 1980 Jul; 28(1):121-9. PubMed ID: 7389249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution to the pharmacokinetics of amitriptyline.
    Ziegler VE; Biggs JT; Ardekani AB; Rosen SH
    J Clin Pharmacol; 1978 Oct; 18(10):462-7. PubMed ID: 711927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amitriptyline metabolism: association with debrisoquin hydroxylation in nonsmokers.
    Mellström B; Säwe J; Bertilsson L; Sjöqvist F
    Clin Pharmacol Ther; 1986 Apr; 39(4):369-71. PubMed ID: 3956053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic interaction between diltiazem and nortriptyline.
    Krähenbühl S; Smith-Gamble V; Hoppel CL
    Eur J Clin Pharmacol; 1996; 49(5):417-9. PubMed ID: 8866640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
    Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
    J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
    Nordin C; Bertilsson L; Siwers B
    Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Column switching and high-performance liquid chromatography in the analysis of amitriptyline, nortriptyline and hydroxylated metabolites in human plasma or serum.
    Härtter S; Hiemke C
    J Chromatogr; 1992 Jul; 578(2):273-82. PubMed ID: 1400807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and disposition of trifluoperazine in the rat. II. Kinetics after oral and intravenous administration in acutely and chronically treated animals.
    Schmalzing G
    Drug Metab Dispos; 1977; 5(2):104-15. PubMed ID: 15802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alprazolam does not inhibit the metabolism of nortriptyline in depressed patients or inhibit the metabolism of desipramine in human liver microsomes.
    Bertilsson L; Aberg-Wistedt A; Lidén A; Otani K; Spina E
    Ther Drug Monit; 1988; 10(2):231-3. PubMed ID: 3381243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of nortriptyline during monotherapy and during concomitant treatment with drugs that inhibit CYP2D6--an evaluation with the nonparametric maximum likelihood method.
    Jerling M; Merlé Y; Mentré F; Mallet A
    Br J Clin Pharmacol; 1994 Nov; 38(5):453-62. PubMed ID: 7893588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings.
    Dahl-Puustinen ML; Perry TL; Dumont E; von Bahr C; Nordin C; Bertilsson L
    Clin Pharmacol Ther; 1989 Jun; 45(6):650-6. PubMed ID: 2731406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio.
    Nordin C; Siwers B; Benitez J; Bertilsson L
    Br J Clin Pharmacol; 1985 Jun; 19(6):832-5. PubMed ID: 4027124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man.
    Gram LF; Andreasen PB; Overo KF; Christiansen J
    Psychopharmacology (Berl); 1976 Oct; 50(1):21-7. PubMed ID: 827758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed.
    McCue RE; Georgotas A; Nagachandran N; Abdul Basir M; Go EA; Suckow RF; Cooper TB
    J Psychiatr Res; 1989; 23(1):73-9. PubMed ID: 2754630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients.
    Montgomery SA; McAuley R; Montgomery DB; Braithwaite RA; Dawling S
    Clin Pharmacokinet; 1979; 4(2):129-36. PubMed ID: 378500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nortriptyline therapy in elderly patients: dosage prediction from plasma concentration at 24 hours after a single 50 mg dose.
    Dawling S; Crome P; Heyer EJ; Lewis RR
    Br J Psychiatry; 1981 Nov; 139():413-6. PubMed ID: 7332844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.